LISATA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
LISATA THERAPEUTICS, INC. (LSTA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 4.01 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 4.01K shares, a 77.61% decline year-over-year.
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 0.00 shares.
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 0.00 shares.
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 17.93K shares, a 568.78% increase from fiscal 2024.
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 2.68K shares, a 98.15% decline from fiscal 2023.
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 144.59K shares, a 2374.23% increase from fiscal 2022.
- LISATA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 5.84K shares, a 80.42% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 4.01K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 4.01K shares 10-Q · filed 2026-08-06 | 4.01K shares derived: sum of 3 quarters · filed 2026-08-06 | 4.01K shares derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-11 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-11 | 0.00 shares derived: sum of 3 quarters · filed 2026-05-11 | 17.93K shares derived: sum of 4 quarters · filed 2026-05-11 | |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-12 | 17.93K shares derived: sum of 3 quarters · filed 2026-03-12 | 17.93K shares 10-K · filed 2026-03-12 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 17.93K shares derived: sum of 2 quarters · filed 2025-11-06 | 17.93K shares 10-Q · filed 2025-11-06 | 17.93K shares derived: sum of 4 quarters · filed 2025-11-06 | |
| 2025-06-30 | 17.93K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 17.93K shares 10-Q · filed 2025-08-07 | 17.93K shares derived: sum of 3 quarters · filed 2025-08-07 | 20.61K shares derived: sum of 4 quarters · filed 2025-08-07 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | 0.00 shares derived: sum of 2 quarters · filed 2025-05-08 | 2.68K shares derived: sum of 3 quarters · filed 2025-05-08 | 2.68K shares derived: sum of 4 quarters · filed 2025-05-08 | |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 2.68K shares derived: sum of 2 quarters · filed 2025-02-27 | 2.68K shares derived: sum of 3 quarters · filed 2025-02-27 | 2.68K shares 10-K · filed 2025-02-27 | |
| 2024-09-30 | 2.68K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 2.68K shares derived: sum of 2 quarters · filed 2024-11-12 | 2.68K shares 10-Q · filed 2024-11-12 | 2.68K shares derived: sum of 4 quarters · filed 2024-11-12 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 0.00 shares 10-Q · filed 2024-08-12 | 0.00 shares derived: sum of 3 quarters · filed 2024-08-12 | 1.90K shares derived: sum of 4 quarters · filed 2024-08-12 | |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-09 | 0.00 shares derived: sum of 2 quarters · filed 2024-05-09 | 1.90K shares derived: sum of 3 quarters · filed 2024-05-09 | 144.59K shares derived: sum of 4 quarters · filed 2024-05-09 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 1.90K shares derived: sum of 2 quarters · filed 2024-02-29 | 144.59K shares derived: sum of 3 quarters · filed 2024-02-29 | 144.59K shares 10-K · filed 2024-02-29 | |
| 2023-09-30 | 1.90K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 144.59K shares derived: sum of 2 quarters · filed 2023-11-02 | 144.59K shares 10-Q · filed 2023-11-02 | 147.53K shares derived: sum of 4 quarters · filed 2023-11-02 | |
| 2023-06-30 | 142.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 142.69K shares 10-Q · filed 2023-08-14 | 145.63K shares derived: sum of 3 quarters · filed 2023-08-14 | 131.04K shares derived: sum of 4 quarters · filed 2023-08-14 | |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-09 | 2.93K shares derived: sum of 2 quarters · filed 2023-05-09 | -11.66K shares derived: sum of 3 quarters · filed 2023-05-09 | -3.72K shares derived: sum of 4 quarters · filed 2023-05-09 | |
| 2022-12-31 | 2.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -11.66K shares derived: sum of 2 quarters · filed 2023-03-30 | -3.72K shares derived: sum of 3 quarters · filed 2023-03-30 | 5.84K shares 10-K · filed 2023-03-30 | |
| 2022-09-30 | -14.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -6.66K shares derived: sum of 2 quarters · filed 2022-11-10 | 2.91K shares 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | 7.93K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 17.50K shares 10-Q · filed 2022-08-04 | |||
| 2022-03-31 | 9.56K shares 10-Q · filed 2022-05-05 | ||||
| 2021-12-31 | 29.84K shares 10-K · filed 2022-03-22 | ||||
| 2020-12-31 | 86.25K shares 10-K · filed 2021-02-25 | ||||
| 2019-12-31 | 2.63K shares 10-K · filed 2020-03-05 | ||||
| 2012-06-30 | 1.17M shares 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |